The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin

Shu-Ting Chen1, Maiko Okada2, Ryuichiro Nakato1

  • 1From the Research Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032 and.

Insights

The deubiquitinating enzyme USP7 is a novel co-regulator of the androgen receptor (AR) in prostate cancer. Inhibiting USP7 may offer a new therapeutic strategy for treating prostate cancer by blocking AR signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The androgen receptor (AR) is crucial in prostate cancer, but current therapies are limited by AR signaling heterogeneity.
  • Understanding AR reactivation mechanisms is vital for developing new prostate cancer treatments.

Purpose of the Study:

  • To identify novel co-regulators of the androgen receptor (AR) involved in prostate cancer.
  • To investigate the role of the deubiquitinating enzyme USP7 in AR transcriptional activity.

Main Methods:

  • Antibody-based affinity purification to identify AR-interacting proteins.
  • Biochemical assays to assess AR deubiquitination and androgen-dependent association.
  • Chromatin immunoprecipitation (ChIP) assays to determine USP7-AR complex formation on target gene promoters.
  • Transcriptome profiling of USP7-knockdown cells.

Main Results:

  • USP7 was identified as a novel AR co-regulator in prostate cancer cells.
  • USP7 associates with AR in an androgen-dependent manner and mediates AR deubiquitination.
  • USP7 facilitates AR binding to chromatin at androgen-responsive elements and is essential for the expression of key androgen-responsive genes.

Conclusions:

  • USP7 plays a critical role in regulating androgen receptor transcriptional activity in prostate cancer.
  • USP7 inhibition represents a promising therapeutic strategy for prostate cancer treatment.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.5K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
7.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K